CoChat

Luteolin and Thiosalicylate Inhibit HGCL2and Thimerosal-Induced VEGF Release from Human Mast Cells

Asadi, S., Zhang, B., Weng, Z., Angelidou, A., Kempuraj, D., Alysandratos, K.D., Theoharides, T.C. · 2010 · International Journal of Immunopathology and Pharmacology
Cited by 40

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

HgCl 2 is a known environmental neurotoxin, but is also used as preservative in vaccines as thimerosal containing ethyl mercury covalently linked to thiosalicylate. We recently reported that mercury chloride (HgCl 2) can stimulate human mast cells to release vascular endothelial growth factor (VEGF), which is also vasoactive and pro-inflammatory. Here we show that thimerosal induces significant VEGF release from human leukemic cultured LAD2 mast cells (at 1 μM 326±12 pg/10 6 cells and 335.5±12 pg/10 6 cells at 10 μM) compared to control cells (242±21 pg/10 6 cells, n=5, p<0.05); this effect is weaker than that induced by HgCl 2 at 10 μM (448±14 pg/10 6 cells) (n=3, p<0.05). In view of this finding, we hypothesize that the thiosalicylate component of thimerosal may have an inhibitory effect on VEGF release. Thimerosal (10 μM) added together with the peptide Substance P (SP) at 2 μM, used as a positive control, reduced VEGF release by 90%. Methyl thiosalicylate (1 or 10 μM) added with either SP or HgCl 2(10 μM) inhibited VEGF release by 100%, while sodium salicylate or ibuprofen had no effect. Pretreatment for 10 min with the flavonoid luteolin (0.1 mM) before HgCI 2 or thimerosal completely blocked their effect. Luteolin and methyl thiosalicylate may be useful in preventing mercury-induced toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/039463201002300406

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 40

Metadata

Authors
Asadi, S., Zhang, B., Weng, Z., Angelidou, A., Kempuraj, D., Alysandratos, K. D., & Theoharides, T. C.
Venue
International Journal of Immunopathology and Pharmacology
Published
2010-10
Volume
23
Issue
4
Pages
1015-1020
ISSN
  • 0394-6320 (ISSN-L)
  • 2058-7384
OpenAlex
W130884863
Cited by
40
References
4
FWCI
1.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Luteolin and Thiosalicylate Inhibit HGCL2and Thimerosal-Induced VEGF Release from Human Mast Cells. https://app.cochat.ai/papers/10.1177/039463201002300406
The paper
Asadi, S., Zhang, B., Weng, Z., Angelidou, A., Kempuraj, D., Alysandratos, K. D., & Theoharides, T. C. (2010). Luteolin and Thiosalicylate Inhibit HGCL2and Thimerosal-Induced VEGF Release from Human Mast Cells. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/039463201002300406

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.